Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. (Q52031352)

20 April 2018

title

Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. (English)

1 reference

20 April 2018

main subject

Neisseria meningitidis

1 reference

P Richmond

1

1 reference

20 April 2018

D Goldblatt

2

1 reference

20 April 2018

P C Fusco

3

1 reference

20 April 2018

J D Fusco

4

1 reference

20 April 2018

I Heron

5

1 reference

20 April 2018

S Clark

6

1 reference

20 April 2018

R Borrow

7

1 reference

20 April 2018

F Michon

8

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 November 1999

1 reference

20 April 2018

published in

Vaccine

1 reference

20 April 2018

volume

18

1 reference

20 April 2018

issue

7-8

1 reference

20 April 2018

page(s)

641-646

1 reference

20 April 2018

The epidemiology of meningococcal disease in England and Wales, 1996 and 1997

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Improved ELISA for determination of anti-diphtheria and/or anti-tetanus antitoxin antibodies in sera.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Human immunity to the meningococcus. I. The role of humoral antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Specificity of antibodies to O-acetyl-positive and O-acetyl-negative group C meningococcal polysaccharides in sera from vaccinees and carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Comparative Immunogenicity of Vaccines Prepared from Capsular Polysaccharides of Group C Neisseria meningitidis O.Acetyl.Positive and O.Acetyl.Negative Variants and Escherichia coli K92 in Adult Volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900276-5

7 January 2021

10.1016/S0264-410X(99)00276-5

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018